Home › Essential Thrombocythemia › Michigan
Essential Thrombocythemia clinical trials in Michigan
3 studies for Essential Thrombocythemia are looking for participants at sites in Michigan.
Cities in Michigan
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- University of Michigan Rogel Cancer Center Adult Bone Marrow Transplant Clinic, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07623200A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- University of Michigan ( Site 6000), Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT06351631A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
- Site US06, Ann Arbor
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07849231From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.